DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0027877 | Neuronal Ceroid-Lipofuscinoses | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0007112 | Adenocarcinoma of prostate | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0007789 | Cerebral Palsy | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0022661 | Kidney Failure, Chronic | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0035222 | Respiratory Distress Syndrome, Adult | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0014130 | Endocrine System Diseases | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0032027 | Pityriasis Rubra Pilaris | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0278701 | Gastric Adenocarcinoma | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0007760 | Cerebellar Diseases | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0393593 | Dystonia Disorders | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0600427 | Cocaine Dependence | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0362046 | Prediabetes syndrome | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0018801 | Heart failure | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C1862382 | SVEINSSON CHORIORETINAL ATROPHY | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0343804 | Chronic Chagas' disease | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0007570 | Celiac Disease | GAD1 | 2571 | glutamate decarboxylase 1 | Q99259 |
C0600139 | Prostate carcinoma | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0085207 | Gestational Diabetes | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C1837461 | SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0376358 | Malignant neoplasm of prostate | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0029408 | Degenerative polyarthritis | PLA2G4F | 255189 | phospholipase A2 group IVF | Q68DD2 |
C0017921 | Glycogen storage disease type II | GAA | 2548 | glucosidase alpha, acid | P10253 |
C0241005 | Creatine phosphokinase serum increased | GAA | 2548 | glucosidase alpha, acid | P10253 |
C0751173 | Glycogen Storage Disease Type II, Infantile | GAA | 2548 | glucosidase alpha, acid | P10253 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024